Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. [electronic resource]
Producer: 20091124Description: 612-21 p. digitalISSN:- 1539-3704
- Anti-Inflammatory Agents, Non-Steroidal -- economics
- Antirheumatic Agents -- economics
- Arthritis, Rheumatoid -- diagnostic imaging
- Cost-Benefit Analysis
- Decision Support Techniques
- Disease Progression
- Glucocorticoids -- economics
- Health Care Costs
- Humans
- Immunologic Factors -- economics
- Methotrexate -- economics
- Quality-Adjusted Life Years
- Radiography
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.